American Diabetes Association
-
Publisher Of
-
Professional Practice Committee: Standards of Medical Care in Diabetes—2020.
Diabetes Care.
43:S3-S3.
2020
-
Implementation of A1C Point-of-Care Testing: Serving Under-Resourced Adults With Type 2 Diabetes in a Public Health Department.
Clinical Diabetes : a Publication of the American Diabetes Association.
37:242-249.
2019
-
Professional Practice Committee: Standards of Medical Care in Diabetes—2019.
Diabetes Care.
42:S3-S3.
2019
-
Erratum. National Institutes of Health–Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing Facilities. Diabetes 2016;65:3418–3428.
Diabetes.
66:2531.1-2531.
2017
-
Maternal Glucose and Fatty Acid Kinetics and Infant Birth Weight in Obese Women With Type 2 Diabetes.
Diabetes.
65:893-901.
2016
-
Expanding Treatment Options for Youth With Type 2 Diabetes: Current Problems and Proposed Solutions.
Diabetes Care.
39:323-329.
2016
-
Semaphorin3a Promotes Advanced Diabetic Nephropathy.
Diabetes.
64:1743-1759.
2015
-
Remogliflozin Etabonate, a Selective Inhibitor of the Sodium-Glucose Transporter 2, Improves Serum Glucose Profiles in Type 1 Diabetes.
Diabetes Care.
35:2198-2200.
2012
-
Transcriptome Analysis of Human Diabetic Kidney Disease.
Diabetes.
60:2354-2369.
2011
-
Whole-Body Proteolysis Rate Is Elevated in HIV-Associated Insulin Resistance.
Diabetes.
55:2849-2855.
2006
-
Novel hepatoselective insulin analog: studies with a covalently linked thyroxyl-insulin complex in humans.
Diabetes Care.
23:1124-1129.
2000
-
Leptin directly alters lipid partitioning in skeletal muscle.
Diabetes.
46:1360-1363.
1997
-
Diet-induced type II diabetes in C57BL/6J mice.
Diabetes.
37:1163-1167.
1988
-
Relaxation Therapy: A Reply.
Diabetes Care.
10:794-795.
1987
-
Cognitive Functioning and Diabetes: A Reply.
Diabetes Care.
10:136-137.
1987
-
A Double-Blind Crossover Trial Comparing Human Insulin (recombinant DNA) with Animal Insulins in the Treatment of Previously Insulin-treated Diabetic Patients.
Diabetes Care.
5:129-134.
1982
-
For Reading on Writing.
Diabetes Care.
3:198-198.
1980
-
Familial Partial Lipodystrophy.
Alexandria, VA.
2018
-
Inpatient Insulin Management for Complex Enteral Feedings.
Alexandria, VA.
2015
-
Transitioning from Intravenous to Subcutaneous Insulin in a Complicated Patient.
Alexandria, VA.
2015
-
1839-P: Glycemic Control Impacts Severity of Hepatic Fibrosis in NAFLD/NASH.
Diabetes.
1839-P.
2020
-
1848-P: Insulin Sensitivity and Metabolic Profile of Subjects with Type 2 Diabetes and Nonalcoholic Steatohepatitis after Exposure to Cenicriviroc: A Subanalysis of the CENTAUR Study.
Diabetes.
1848-P.
2020
-
526-P: Urine Tricarboxylic Acid Cycle Organic Anions and Progression of Diabetic Kidney Disease.
Diabetes.
526-P.
2020
-
1016-P: A Novel GLP-1 and FGF-21 Dual Agonist Drug Protects Mice from Obesity and Hyperglycemia.
Diabetes.
1016-P.
2019
-
1148-P: Cenicriviroc Safety in over 1,200 Subjects.
Diabetes.
1148-P.
2019
-
1164-P: Effects of Cenicriviroc in Adults with NASH on Inflammatory Cytokines and Metabolic Parameters.
Diabetes.
1164-P.
2019
-
136-OR: Efficacy of Cenicriviroc (CVC) in Adults with NASH-Induced Liver Fibrosis.
Diabetes.
136-OR.
2019
-
140-LB: NGM313, a Novel Activator of b-Klotho/FGFR1c, Improves Insulin Resistance and Reduces Hepatic Fat in Obese, Nondiabetic Subjects.
Diabetes.
140-LB.
2019
-
175-LB: Effect of a Telemedicine Diabetic Foot Ulcer Intervention on Health and Well-Being: A Cluster Randomized Controlled Trial.
Diabetes.
175-LB.
2019
-
2191-P: PPM1K Regulates ß-Cell Proliferation, Insulin Content, and GSIS.
Diabetes.
2191-P.
2019
-
329-OR: Shared Medical Appointments (SMA) with Weight Management vs. SMA Alone for Overweight or Obese Patients with Type 2 Diabetes.
Diabetes.
329-OR.
2019
-
EXSCEL—Once-Weekly Exenatide Reduces Medical Resource Utilization in Patients with Type 2 Diabetes Mellitus.
Diabetes.
1319-P.
2018
-
Impact of SGLT2 Inhibitors (SGLT2i) on Cardiovascular (CV) Risk and Estimated Glomerular Filtration Rate (eGFR) in the EXSCEL Placebo Group.
Diabetes.
130-LB.
2018
-
NGM282 Significantly Reduces Hepatic Steatosis Independent of Type 2 Diabetes (T2D) Status or Statin Usage—Results from a Phase 2 Trial in Patients with Nonalcoholic Steatohepatitis (NASH).
Diabetes.
1-LB.
2018
-
Preoperative Hemoglobin A1c Predicts Postoperative Weight Loss following Bariatric Surgery in Patients with Diabetes.
Diabetes.
2045-P.
2018
-
Renal Outcomes in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL).
Diabetes.
522-P.
2018